Safety of a New Chewable Formulation of Mebendazole for Preventive Chemotherapy Interventions to Treat Young Children in Countries with Moderate-to-High Prevalence of Soil Transmitted Helminth Infections

The primary objective was to evaluate the safety and tolerability of the new chewable formulation of mebendazole to treat soil-transmitted helminth (STH) infections in children ≤10 years old with the goal of using this formulation in preventive chemotherapy programs and expand treatment to young chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedman, Andrew J., Ali, Said M., Albonico, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540782/
https://www.ncbi.nlm.nih.gov/pubmed/23319961
http://dx.doi.org/10.1155/2012/590463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540782/
https://www.ncbi.nlm.nih.gov/pubmed/23319961
http://dx.doi.org/10.1155/2012/590463

Ejemplares similares